News and Media

The Amal lab combines advanced omics technologies with computational biology, biochemical, pharmacological and behavioral methods to discover novel drug targets and biomarkers in autism spectrum disorders and other neurological diseases.

Ms. Shelly Ginzburg received the NanoMed Prize of the Nanomed and Nanotechnology Center of the Hebrew University. 

Dr. Haitham Amal has received the Brettler Centre for Research in Molecular Pharmacology and Therapeutics Grant, 2020.

Dr. Haitham Amal has received the prestigious MAOF  Fellowship for Excellent Young Scientist from the Council for Higher Education, 2020.

Dr. Haitham Amal received the prestigious Golda Meir Fellowship Lectureship Award, 2020.

Ynet features the Amal Lab: 

  • LinkedIn
  • Twitter